1. Home
  2. LAB vs DBCA Comparison

LAB vs DBCA Comparison

Compare LAB & DBCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.80

Market Cap

402.1M

Sector

Industrials

ML Signal

HOLD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

N/A

Current Price

$9.97

Market Cap

429.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LAB
DBCA
Founded
1999
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Blank Checks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
402.1M
429.7M
IPO Year
2008
2026

Fundamental Metrics

Financial Performance
Metric
LAB
DBCA
Price
$0.80
$9.97
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.35
N/A
AVG Volume (30 Days)
3.0M
73.0K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
61.54
N/A
EPS
0.33
N/A
Revenue
$101,937,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.63
N/A
P/E Ratio
$2.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$9.83
52 Week High
$1.72
$10.07

Technical Indicators

Market Signals
Indicator
LAB
DBCA
Relative Strength Index (RSI) 34.65 62.92
Support Level N/A $9.87
Resistance Level $1.02 $10.07
Average True Range (ATR) 0.10 0.02
MACD -0.01 0.00
Stochastic Oscillator 2.43 35.48

Price Performance

Historical Comparison
LAB
DBCA

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

About DBCA D. Boral Acquisition I Corp. Class A Ordinary Shares

D Boral Acquisition I Corp is a blank check company. It is formed as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: